The FDA head lauded the White House's new plan to reduce prescription drug costs, calling it a "major step." Drug giant Pfizer has agreed to offer significant discounts on medications through a new government platform, TrumpRx, aiming to align US prices with those paid in Europe. While proponents hail it as a crucial reset for healthcare costs, experts express skepticism about its impact on most Americans' out-of-pocket expenses, suggesting that only a small number may benefit directly.

Prepared by Christopher Adams and reviewed by editorial team.